The potential application of granulocyte colony stimulating factor therapy on neuropathic pain

Long Sun Ro, Shyue Ru Chen, Po Kuan Chao, Yun Lin Lee, Kwok-Tung Lu

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

The precise definition of the International Association for the Study of Pain (IASP) revised in 2008 states that neuropathic pain is a type of pain arising as a direct consequence of a lesion or disease affecting the somatosensory system. This kind of pain is due to long-term dysfunction of the nervous system and is clinically characterized by spontaneous and evoked types of chronic pain, which are involved by various distinct pathophysiological mechanisms in the peripheral and central nervous systems. It is relatively common, with an incidence estimated at 0.6% to 1.5% in the US population. Unfortunately, there was no effective therapy until recently. Our research team found an effective strategy in treating neuropathic pain that resulted from interactions between leukocyte-derived opioid peptides and their receptors on peripheral sensory neurons. Here, we briefly review granulocyte colony stimulating factor (G-CSF) therapy in an animal model of neuropathic pain. Our studies also proved that G-CSF can increase the number of opioid-contained polymorphonuclear cells and significantly relieve neuropathic pain. These studies have led to an increased understanding of the opioids and cytokines -modulating peripheral analgesia effect on neuropathic pain, which opens a new avenue in its treatment.

Original languageEnglish
Pages (from-to)235-246
Number of pages12
JournalChang Gung Medical Journal
Volume32
Issue number3
Publication statusPublished - 2009 May 1

Fingerprint

granulocyte colony-stimulating factor
pain
Neurology
Neuralgia
Granulocyte Colony-Stimulating Factor
nervous system
Opioid Analgesics
therapy
therapeutics
Peptide Receptors
Opioid Peptides
lesion
peptide
Neurons
Animals
Cytokines
animal
narcotics
Therapeutics
Pain

Keywords

  • Cytokine
  • Granulocyte colony stimulating factor (G-CSF) therapy
  • Inflammation
  • Neuropathic pain
  • Opioid peptides
  • Polymorphonuclear cell (PMN)

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The potential application of granulocyte colony stimulating factor therapy on neuropathic pain. / Ro, Long Sun; Chen, Shyue Ru; Chao, Po Kuan; Lee, Yun Lin; Lu, Kwok-Tung.

In: Chang Gung Medical Journal, Vol. 32, No. 3, 01.05.2009, p. 235-246.

Research output: Contribution to journalReview article

Ro, Long Sun ; Chen, Shyue Ru ; Chao, Po Kuan ; Lee, Yun Lin ; Lu, Kwok-Tung. / The potential application of granulocyte colony stimulating factor therapy on neuropathic pain. In: Chang Gung Medical Journal. 2009 ; Vol. 32, No. 3. pp. 235-246.
@article{34576f469cb24664a2f725c7fe78ff16,
title = "The potential application of granulocyte colony stimulating factor therapy on neuropathic pain",
abstract = "The precise definition of the International Association for the Study of Pain (IASP) revised in 2008 states that neuropathic pain is a type of pain arising as a direct consequence of a lesion or disease affecting the somatosensory system. This kind of pain is due to long-term dysfunction of the nervous system and is clinically characterized by spontaneous and evoked types of chronic pain, which are involved by various distinct pathophysiological mechanisms in the peripheral and central nervous systems. It is relatively common, with an incidence estimated at 0.6{\%} to 1.5{\%} in the US population. Unfortunately, there was no effective therapy until recently. Our research team found an effective strategy in treating neuropathic pain that resulted from interactions between leukocyte-derived opioid peptides and their receptors on peripheral sensory neurons. Here, we briefly review granulocyte colony stimulating factor (G-CSF) therapy in an animal model of neuropathic pain. Our studies also proved that G-CSF can increase the number of opioid-contained polymorphonuclear cells and significantly relieve neuropathic pain. These studies have led to an increased understanding of the opioids and cytokines -modulating peripheral analgesia effect on neuropathic pain, which opens a new avenue in its treatment.",
keywords = "Cytokine, Granulocyte colony stimulating factor (G-CSF) therapy, Inflammation, Neuropathic pain, Opioid peptides, Polymorphonuclear cell (PMN)",
author = "Ro, {Long Sun} and Chen, {Shyue Ru} and Chao, {Po Kuan} and Lee, {Yun Lin} and Kwok-Tung Lu",
year = "2009",
month = "5",
day = "1",
language = "English",
volume = "32",
pages = "235--246",
journal = "Chang Gung Medical Journal",
issn = "2072-0939",
number = "3",

}

TY - JOUR

T1 - The potential application of granulocyte colony stimulating factor therapy on neuropathic pain

AU - Ro, Long Sun

AU - Chen, Shyue Ru

AU - Chao, Po Kuan

AU - Lee, Yun Lin

AU - Lu, Kwok-Tung

PY - 2009/5/1

Y1 - 2009/5/1

N2 - The precise definition of the International Association for the Study of Pain (IASP) revised in 2008 states that neuropathic pain is a type of pain arising as a direct consequence of a lesion or disease affecting the somatosensory system. This kind of pain is due to long-term dysfunction of the nervous system and is clinically characterized by spontaneous and evoked types of chronic pain, which are involved by various distinct pathophysiological mechanisms in the peripheral and central nervous systems. It is relatively common, with an incidence estimated at 0.6% to 1.5% in the US population. Unfortunately, there was no effective therapy until recently. Our research team found an effective strategy in treating neuropathic pain that resulted from interactions between leukocyte-derived opioid peptides and their receptors on peripheral sensory neurons. Here, we briefly review granulocyte colony stimulating factor (G-CSF) therapy in an animal model of neuropathic pain. Our studies also proved that G-CSF can increase the number of opioid-contained polymorphonuclear cells and significantly relieve neuropathic pain. These studies have led to an increased understanding of the opioids and cytokines -modulating peripheral analgesia effect on neuropathic pain, which opens a new avenue in its treatment.

AB - The precise definition of the International Association for the Study of Pain (IASP) revised in 2008 states that neuropathic pain is a type of pain arising as a direct consequence of a lesion or disease affecting the somatosensory system. This kind of pain is due to long-term dysfunction of the nervous system and is clinically characterized by spontaneous and evoked types of chronic pain, which are involved by various distinct pathophysiological mechanisms in the peripheral and central nervous systems. It is relatively common, with an incidence estimated at 0.6% to 1.5% in the US population. Unfortunately, there was no effective therapy until recently. Our research team found an effective strategy in treating neuropathic pain that resulted from interactions between leukocyte-derived opioid peptides and their receptors on peripheral sensory neurons. Here, we briefly review granulocyte colony stimulating factor (G-CSF) therapy in an animal model of neuropathic pain. Our studies also proved that G-CSF can increase the number of opioid-contained polymorphonuclear cells and significantly relieve neuropathic pain. These studies have led to an increased understanding of the opioids and cytokines -modulating peripheral analgesia effect on neuropathic pain, which opens a new avenue in its treatment.

KW - Cytokine

KW - Granulocyte colony stimulating factor (G-CSF) therapy

KW - Inflammation

KW - Neuropathic pain

KW - Opioid peptides

KW - Polymorphonuclear cell (PMN)

UR - http://www.scopus.com/inward/record.url?scp=67651154702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651154702&partnerID=8YFLogxK

M3 - Review article

C2 - 19527602

AN - SCOPUS:67651154702

VL - 32

SP - 235

EP - 246

JO - Chang Gung Medical Journal

JF - Chang Gung Medical Journal

SN - 2072-0939

IS - 3

ER -